Central Nervous System Tumors Clinical Trial
Official title:
A Clinical Study of Oncolytic Virus (OH2) Injection in the Treatment of Patients Undergoing Surgery After Recurrence of Central Nervous System Tumors
In the first phase, it mainly explores the safety, tolerability and preliminary effectiveness of two doses of OH2 injection in the treatment of patients with recurrent central nervous system tumors; to evaluate the biodistribution and virus shedding of OH2 injection administered in the tumor cavity; to evaluate the level of anti-HSV2 antibody in patients when OH2 injection is administered intracavitary to tumor; to determine the phase II recommended dose (RP2D) of OH2 injection in the treatment of recurrent glioblastoma. Phase IIa, to evaluate the preliminary efficacy of OH2 injection in the treatment of patients with recurrent glioblastoma after surgery, and to further evaluate the safety of OH2 in the treatment of relapsed glioblastoma.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00876993 -
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
|
Phase 1 | |
| Completed |
NCT00003935 -
Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
|
Phase 1 | |
| Terminated |
NCT00107471 -
Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
|
Phase 1/Phase 2 | |
| Completed |
NCT00003573 -
Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
|
Phase 2 | |
| Suspended |
NCT05308407 -
POWER UP: Participating Online While Exercising to Recover Using Play
|
N/A | |
| Terminated |
NCT00477503 -
Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA
|
Phase 1 | |
| Active, not recruiting |
NCT01985451 -
Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma （PCNSL）
|
Phase 2 | |
| Withdrawn |
NCT00109798 -
Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma
|
N/A | |
| Completed |
NCT00003203 -
Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors
|
Phase 2 | |
| Completed |
NCT00003141 -
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
|
Phase 1 | |
| Completed |
NCT02462629 -
Study of BLZ-100 in Pediatric Subjects With CNS Tumors
|
Phase 1 | |
| Active, not recruiting |
NCT01735747 -
Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma
|
Phase 2 | |
| Recruiting |
NCT00607984 -
Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors
|
N/A | |
| Completed |
NCT00899834 -
DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma
|
N/A | |
| Completed |
NCT00066248 -
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
|
Phase 2 | |
| Completed |
NCT00187226 -
A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects
|
Phase 2 | |
| Completed |
NCT02793466 -
Durvalumab in Pediatric and Adolescent Patients
|
Phase 1 | |
| Withdrawn |
NCT01052363 -
OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas
|
Phase 1 | |
| Completed |
NCT00047320 -
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
|
Phase 2 | |
| Completed |
NCT00945828 -
Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors
|
N/A |